Downregulation of HNRNPK in human cancer cells inhibits lung metastasis

BACKGROUND: Lung cancer frequently occurs in the clinic, leading to poor prognosis and high mortality. Markers for early diagnosis of lung cancer are scarce, and further potential therapeutic targets are also urgently needed. METHOD: We established a new mouse model in which the specific gene HNRNPK...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengyuan, Zhang, Wenlong, Yang, Xingjiu, Liu, Hongfei, Cao, Lin, Li, Weisha, Wang, Le, Zhang, Guoxin, Gao, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930993/
https://www.ncbi.nlm.nih.gov/pubmed/31942561
http://dx.doi.org/10.1002/ame2.12090
Descripción
Sumario:BACKGROUND: Lung cancer frequently occurs in the clinic, leading to poor prognosis and high mortality. Markers for early diagnosis of lung cancer are scarce, and further potential therapeutic targets are also urgently needed. METHOD: We established a new mouse model in which the specific gene HNRNPK (heterogeneous nuclear ribonucleoprotein K) was downregulated after administration of doxycycline. The lung metastatic nodules were investigated using bioluminescence imaging, micro‐CT, and autopsy quantification. RESULTS: Compared with the short hairpin negative control group, less lung metastatic nodules were formed in the short hairpin RNA group. CONCLUSION: Downregulation of HNRNPK in cancer cells can inhibit lung metastasis.

Ejemplares similares